Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine
Topal, B.; Kanra, G.; Ceyhan, M.
Turkish Journal of Pediatrics 33(1): 13-18
1991
ISSN/ISBN: 0041-4301 PMID: 1844171 Document Number: 384941
Fifty-two of 298 children vaccinated with the measles-mumps-rubella (MMR) vaccine at around the age of 16 months were evaluated for antibody titres against mealses, mumps, and rubella. The seropositivity rates for measles, mumps, and rubella were 86%, 92%, and 98%, respectively. While the most prominent side effects were irritability (6.04%) and fever (4.69%), 83.55% of the vaccinated children showed no undesirable reaction to the vaccine. The MMR vaccine appeared to be immunogenic and nonreactogenic for the children in the study.